MedTech Presentations The New Future of US Telehealth: Lasting Impacts of COVID-19 April 23, 2020 COVID-19 has necessitated a broad increase in telehealth’s role across mainstream care delivery use cases, driven by social distancing, need for virtual…
Life Sciences & Pharma Special Report Gene Therapy: Competitive Dynamics and Commercial Implications September 11, 2020 After more than 25 years of investment, commercialization of gene therapies (GTs) has reached a pivotal point.
Biotech and Pharmaceuticals Executive Insights Using Real-World Data to Optimize Pharma Pricing in China September 10, 2020 China has expanded reimbursement coverage for innovative drugs in recent years, with more than 40 new oncology drugs entering the National Reimbursement…
Life Sciences & Pharma Executive Insights Pandemic Preparedness During COVID-19: Biopharma Lessons and Future Implications April 24, 2020 The biopharma industry has accelerated research and development (R&D) timelines. However, therapeutics/vaccines in development are projected to launch…
Life Sciences & Pharma Executive Insights How Value-Based Contracts Bring Value to Biopharma July 23, 2020 Biopharmaceutical executives have engaged in extensive debates about the need for and effectiveness of value-based contracts (VBCs) ever since the…
MedTech Executive Insights COVID-19 and the Acceleration of Digital Health in APAC April 23, 2020 Healthcare stakeholders are implementing drastic measures, including swift deployment of digital health tools, in an effort to curb the spread of the…
